Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

Overview of attention for article published in BMC Cancer, June 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,545 followers.

Esperaremos a los resultados; Within-class differences in cancer risk for sulfonylurea treatments... https://t.co/Ner7RMUnq4

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes… https://t.co/WbX3HUjwdm #breastcancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.